Mingyi Zhizao develops gene sequencing instruments, high-throughput sequencing reagents, enzyme reagents and supporting software. The company focuses on innovation in sequencing technology and sequencing platform development. It recently completed a financing round described as a B++ round of nearly RMB100 million. Proceeds will be used to build a scaled gene sequencing platform production base in Lianyungang, Jiangsu. The company also plans to push sequencer mass production, establish a market promotion network, and accelerate medical device registration and filing. No operating metrics or prior funding details were disclosed in the article.

Total raised

$14M

Funding rounds

1

Latest round

Series B

Latest activity

Dec 2023